Consequently, our methods predict substantially fewer unseen variants in KRAS than in FAT1 (see Fig. 4b), while the corresponding estimate of the probability of observing at least one new variant in a new tumor is noticeably higher for FAT1 as compared to KRAS (Fig. 4a). Here, FAT1 is linked to neoplasm.